Ventoxen is an oral BCL-2 inhibitor primarily used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain forms of acute myeloid leukemia (AML). Dosage and administration vary depending on the condition being treated, as well as patient factors like age, comorbidities, and prior treatments. The following is a ge